Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/PACTR201211000432357
PACTR201211000432357Not yet recruiting未知

Pre-emptive value of methylpredinsolone intravenous infusion in patients with vertebral deposits. Double blinded randomized study

a0 sites120 target enrollmentStarted: October 8, 2012Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
a
Enrollment
120
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Year(s) to 70 Year(s) (—)
Sex
All

Inclusion Criteria

  • •: One hundred twenty patients with class I-III Harrington classification of vertebral metastases included in the study admitted to the oncology department

Exclusion Criteria

  • •Patients with any medical contraindications to corticosteroids, such as diabetes mellitus, uncontrolled hypertension, infection, thrombo-embolic disorders or active peptic ulcer were excluded from the study. Patients with a pathological fracture at the irradiated site, patients with other bone metastases and patients with visceral metastases at the time of radiotherapy were also excluded from the study.

Investigators

Sponsor
a

Similar Trials

Completed
Phase 3
A study about effect of steroid treatment in children with severe epilepsy.
CTRI/2019/02/017807ON FUNDED NIMHANS
Recruiting
Phase 3
The effect of corticosteroid on the treatment of Kawasaki
IRCT20181202041817N1Tehran University of Medical Sciences60
Recruiting
Phase 4
A comparison of intravenous pulse methylprednisolone and dexamethasone on idiopathic sudden sensorineural hearing loss : A double-blind randomized controlled trialidiopathic sudden sensorineural hearing lossIdiopathic sudden sensorineural hearing loss, steroid, intravenous pulsemethylprednisolone, intravenous dexamethasone
TCTR20211224004Sirinkarn Sookdee30
Completed
Not Applicable
Evaluation of effects of methylprednisolone injection in masseter muscle versus deltoid muscle after wisdom tooth removal
CTRI/2022/06/043230The Director70
Completed
Phase 2
Effect of Methylprednisolone in treatment of COVID-19 patientsthe 2019 novel Corona virus (COVID-19).COVID-19 confirmed by laboratory testing.U07.1
IRCT20200204046369N1Shiraz University of Medical Sciences82